Trial Summary
What is the purpose of this trial?
This is a prospective randomized, double-blinded, controlled trial that will enroll 75 subjects undergoing laparoscopic hiatal hernia repair surgery. Participants who meet eligibility criteria will be randomized in a 1:1 ratio to receive either the opioid sparring anesthesia protocol (OSA) or the opioid based anesthesia protocol (OBA). The purpose of this study is to investigate if an opioid sparring protocol for laparoscopic hiatal hernia repair will reduce opioid consumption during discharge. Other outcomes include: postoperative VAS scores (PACU arrival, PACU discharge, hospital discharge), total in hospital opioid consumption, PACU length of stay, incidence of postoperative nausea and vomiting (PONV in PACU, postoperative day 1, during hospital stay), rehospitalization rate, rate of reoperation, rate of emergency room visit, surgeon satisfaction, and hospital cost differential.
Do I have to stop taking my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. Please consult with the trial coordinators for guidance.
What data supports the idea that Anesthesia Protocols for Hiatal Hernia Surgery is an effective treatment?
The available research shows that opioid-free anesthesia (OFA) can be effective in surgeries similar to hiatal hernia surgery, like bariatric and lung surgeries. For example, studies on bariatric surgery suggest that OFA may lead to less need for pain medication after surgery compared to traditional opioid-based anesthesia. Additionally, in lung surgery, OFA was found to reduce the severity of pain after surgery and decrease side effects related to pain management. These findings indicate that OFA could be a beneficial approach for managing pain and recovery in surgeries, potentially including hiatal hernia surgery.12345
What safety data exists for anesthesia protocols in hiatal hernia surgery?
The safety data for anesthesia protocols, including opioid-free and opioid-sparing approaches, suggest potential benefits in reducing postoperative pain and opioid-related side effects. Studies have shown that opioid-free anesthesia (OFA) can reduce the severity of postoperative pain and adverse events in various surgeries, such as lung and bariatric surgeries. Opioid-sparing anesthesia (OSA) and multimodal analgesia are also being explored to minimize opioid use and its associated risks. However, evidence is still evolving, and more research is needed to establish universally accepted protocols.12467
Is the Opioid Sparing Anesthesia Protocol (OSA) a promising treatment for hiatal hernia surgery?
Yes, the Opioid Sparing Anesthesia Protocol (OSA) is promising because it aims to reduce the use of opioids, which can lead to fewer complications and better pain management during and after surgery. This approach is part of a broader effort to minimize opioid use, which is important given the opioid epidemic. Studies have shown that similar protocols in other surgeries have been effective in managing pain while reducing the need for opioids.238910
Eligibility Criteria
This trial is for adults aged 18-90 scheduled for elective laparoscopic hiatal hernia repair surgery. It's not suitable for those needing urgent or non-laparoscopic surgery, or with allergies to drugs used in the anesthesia protocols.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Opioid Based Anesthesia Protocol (OBA) (Other)
- Opioid Sparing Anesthesia Protocol (OSA) (Other)
Opioid Based Anesthesia Protocol (OBA) is already approved in United States, European Union, Canada for the following indications:
- General anesthesia for surgical procedures including laparoscopic hiatal hernia repair
- General anesthesia for surgical procedures including laparoscopic hiatal hernia repair
- General anesthesia for surgical procedures including laparoscopic hiatal hernia repair